233 related articles for article (PubMed ID: 29686054)
1. The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism.
Fensterheim BA; Young JD; Luan L; Kleinbard RR; Stothers CL; Patil NK; McAtee-Pereira AG; Guo Y; Trenary I; Hernandez A; Fults JB; Williams DL; Sherwood ER; Bohannon JK
J Immunol; 2018 Jun; 200(11):3777-3789. PubMed ID: 29686054
[TBL] [Abstract][Full Text] [Related]
2. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages.
Owen AM; Luan L; Burelbach KR; McBride MA; Stothers CL; Boykin OA; Sivanesam K; Schaedel JF; Patil TK; Wang J; Hernandez A; Patil NK; Sherwood ER; Bohannon JK
Front Immunol; 2022; 13():1044662. PubMed ID: 36439136
[TBL] [Abstract][Full Text] [Related]
3. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
Watts BA; Tamayo E; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
[TBL] [Abstract][Full Text] [Related]
4. The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection.
Romero CD; Varma TK; Hobbs JB; Reyes A; Driver B; Sherwood ER
Infect Immun; 2011 Sep; 79(9):3576-87. PubMed ID: 21646453
[TBL] [Abstract][Full Text] [Related]
5. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
[TBL] [Abstract][Full Text] [Related]
6. The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.
Hernandez A; Bohannon JK; Luan L; Fensterheim BA; Guo Y; Patil NK; McAdams C; Wang J; Sherwood ER
J Leukoc Biol; 2016 Dec; 100(6):1311-1322. PubMed ID: 27354411
[TBL] [Abstract][Full Text] [Related]
7. Inefficient TLR4/MD-2 heterotetramerization by monophosphoryl lipid A.
Casella CR; Mitchell TC
PLoS One; 2013; 8(4):e62622. PubMed ID: 23638128
[TBL] [Abstract][Full Text] [Related]
8. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
[TBL] [Abstract][Full Text] [Related]
9. The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling.
Blanco-Pérez F; Goretzki A; Wolfheimer S; Schülke S
Mol Immunol; 2019 Feb; 106():159-169. PubMed ID: 30623816
[TBL] [Abstract][Full Text] [Related]
10. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.
Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A
Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069
[TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl lipid A prevents impairment of medullary thick ascending limb [Formula: see text] absorption and improves plasma [Formula: see text] concentration in septic mice.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F711-F725. PubMed ID: 29741098
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER
Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797
[TBL] [Abstract][Full Text] [Related]
13. TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c
Griffin C; Eter L; Lanzetta N; Abrishami S; Varghese M; McKernan K; Muir L; Lane J; Lumeng CN; Singer K
J Biol Chem; 2018 Jun; 293(23):8775-8786. PubMed ID: 29636416
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
15. MPLA inhibits release of cytotoxic mediators from human neutrophils while preserving efficient bacterial killing.
Ruchaud-Sparagano MH; Mills R; Scott J; Simpson AJ
Immunol Cell Biol; 2014 Oct; 92(9):799-809. PubMed ID: 25001496
[TBL] [Abstract][Full Text] [Related]
16. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
17. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.
Cheng SC; Quintin J; Cramer RA; Shepardson KM; Saeed S; Kumar V; Giamarellos-Bourboulis EJ; Martens JH; Rao NA; Aghajanirefah A; Manjeri GR; Li Y; Ifrim DC; Arts RJ; van der Veer BM; Deen PM; Logie C; O'Neill LA; Willems P; van de Veerdonk FL; van der Meer JW; Ng A; Joosten LA; Wijmenga C; Stunnenberg HG; Xavier RJ; Netea MG
Science; 2014 Sep; 345(6204):1250684. PubMed ID: 25258083
[TBL] [Abstract][Full Text] [Related]
18. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.
Cekic C; Casella CR; Eaves CA; Matsuzawa A; Ichijo H; Mitchell TC
J Biol Chem; 2009 Nov; 284(46):31982-91. PubMed ID: 19759006
[TBL] [Abstract][Full Text] [Related]
19. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite nanoparticles promote TLR4 agonist-mediated anti-tumor immunity through synergically enhanced macrophage polarization.
Wang R; Hua Y; Wu H; Wang J; Xiao YC; Chen X; Ao Q; Zeng Q; Zhu X; Zhang X
Acta Biomater; 2023 Jul; 164():626-640. PubMed ID: 37086827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
